Familial Medullary Thyroid Carcinoma (FMTC)
Module Sequence Completed!
You have processed all queries for this module. Excellent performance!
Explore other knowledge matrices or review your progress.
Social Sharing!
Share your knowledge:
Keep going! After this module, consider:
Adrenal Cortical Neoplasms: Adenoma vs. Carcinoma
Start Next ModuleSuggest Favorite subject or vote for a trending one!
Having trouble? Here are some quick links:
No study tools available yet.
Time on task: 0 mins
No helpful links available yet.
You have processed all queries for this module. Excellent performance!
Explore other knowledge matrices or review your progress.
True. This is a key strength of TMA in standardizing laboratory performance across institutions. An organizing body (like a national pathology society or a proficiency testing provider) can create a master TMA block containing a validated set of tissue samples with known biomarker status. From this single, homogeneous master block, hundreds of identical, thin sections can be cut. These identical sections are then distributed to dozens or hundreds of participating laboratories. Each lab processes their section according to their own standard operating procedure for a specific stain (e.g., HER2 immunohistochemistry). Because every lab is starting with the exact same physical tissue sample on their slide, any differences in the final stained results can be confidently attributed to variables in the labs' own processes—such as antigen retrieval methods, antibody clones, detection systems, or interpretation criteria—and not to pre-analytical differences in the tissue itself. This allows for a fair and precise comparison of inter-laboratory performance.
Break down complex topics into smaller, manageable chunks for easier recall.
Zambia